Table 2 Results of randomized trails of nutrition and nosocomial pneumonia
Intervention (author [reference]) | Pneumonia rates | Relative risk (95% Cl) |
|---|---|---|
Nasogastric enteral nutrition vs parenteral nutrition (Young [22]) | TPN: 6/23 (26%) | 1.23 (0.51–2.95) |
EN: 9/28 (32%) | ||
Jejunostomy feeding vs total parenteral nutrition (Moore [23]) | TPN: 6/30 (20%) | Undefined |
EN: 0/29 (0%) | ||
Jejunostomy feeding vs total parenteral nutrition (Kudsk [24]) | TPN: 14/45 (31%) | 0.38 (0.16–0.90) |
EN: 6/51 (12%) | ||
Jejunostomy feeding vs total parenteral nutrition (Borzotta [25]) | TPN: 9/23 (39%) | 1.06 (0.56–2.02) |
EN: 15/36 (42%) | ||
Early nasoduodenal vs late nasoduodenal feeding (Eyer [26]) | Late: 4/19 (21%) | 2.00 (0.72–5.54) |
Early: 8/19 (42%) | ||
Jejunal vs gastric feeding (Montecalvo [27]) | Gastric: 2/19 (11%) | Undefined |
Jejunal: 0/19 (0%) | ||
Intermittent enteral feeding vs continuous enteral feeding (Bonten [28]) | CEF: 5/30 (17%) | 1.0 (0.32–3.10) |
IEF: 5/30 (17%) | ||
Modular tube feeding (MTF) vs Osmolite vs Traumacal (Gottschlich [29]) | Osmolite: 6/14 (43%) | 0.27 (0.07–1.15)* |
Traumacal: 9/19 (47%) | 0.25 (0.06-0.99)† | |
MTF: 2/17 (12%) | ||
Immun-Aid vs Vivonex (Moore [30]) | Vivonex: 4/47 (9%) | 0.92 (0.24–3.48) |
Immun-Aid: 4/51 (8%) | ||
Immun-Aid vs Promote (Kudsk [31]) | Promote: 3/17 (18%) | Undefined |
Immun-Aid: 0/16 (0%) |